Posts

Showing posts from February, 2025

Using Trademarks to Ensure Completion of Postapproval Trials

This Viewpoint evaluates how using trademarks can support the US Food and Drug Administration’s mission to approve safe and effective medications. from JAMA Health Forum New Online https://ift.tt/vXVJdcZ

Trump’s Most Important Health Policy May Be at the Border

This JAMA Forum discusses immigration in the context of the health care workforce, the potential negative effects from a reduced supply of workers, and potential policy options. from JAMA Health Forum New Online https://ift.tt/DMQyvGk

Addressing Both Racism and Ageism in Research

This Viewpoint assesses an opportunity for epidemiological cohort study the Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) to address critical evidence gaps for groups who have been labeled as “other” in research studies. from JAMA Internal Medicine Online First https://ift.tt/fjeglxk

Unifying Outpatient Practices to Redress Structural Racism in an Urban Health System

This qualitative study investigates the benefits and challenges of addressing health care segregation by unifying outpatient practices within a large urban health system. from JAMA Health Forum New Online https://ift.tt/vbeFzLE

Fillings Needed for Gaps in Government Dental Coverage

This JAMA Forum discusses the current dental coverage available in 3 government health insurance programs (Medicaid, Medicare, and the Affordable Care Act Marketplace) and identifies opportunities for improvement. from JAMA Health Forum New Online https://ift.tt/Gw2KQIo

The Value of Academic Health Research

Health Policy from JAMA Health Forum New Online https://ift.tt/XGW45uE

Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance

This Review summarizes evidence on the diagnosis and management of monoclonal gammopathy of unknown significance to guide clinical decision-making. from JAMA Internal Medicine Online First https://ift.tt/XVNUIeO

Benzocaine-Induced Methemoglobinemia After Nasogastric Tube Insertion

This Teachable Moment describes an 87-year-old man who underwent fatal complications from the use of benzocaine spray for nasopharyngeal anesthesia before the insertion of a nasogastric tube. from JAMA Internal Medicine Online First https://ift.tt/cqVC48A

Drivers of Variation in Health Care Spending Across US Counties

This cross-sectional study estimates the amount of cross-county health care spending variation explained by population age, health conditions prevalence, service utilization, and service price and intensity. from JAMA Health Forum New Online https://ift.tt/TPO4oxD

Sale of Private Equity–Owned Physician Practices and Physician Turnover

This case-control study using data from the Centers for Medicare & Medicaid Services Doctors and Clinicians National Downloadable File compares changes in physician employment in private equity–exiting practices with those of physicians who did not work in these practices during the same period. from JAMA Health Forum New Online https://ift.tt/c12QDWk

Spending After Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure

This cohort study assesses health care costs after initiating sacubitril-valsartan compared to an angiotensin-converting enzyme inhibitor or an angiotensin II receptor-blocker in Medicare patients being treated for heart failure with reduced ejection fraction. from JAMA Health Forum New Online https://ift.tt/kLa5Wd8

Minnesota Law Brings Transparency to the 340B Drug Pricing Program

This Viewpoint discusses the need for visibility into results of the federal 340B Drug Pricing Program and reviews first data from Minnesota. from JAMA Health Forum New Online https://ift.tt/SFXgrD0

Research on Difficult Social Issues—The Consequences of Abortion Bans

Health Policy from JAMA Health Forum New Online https://ift.tt/ktsPKbM

Medicare Opioid Policy and Opioid Use in Beneficiaries With Disabilities

This interrupted time-series cohort study examines the association of the 2019 Medicare opioid safety edits with changes in opioid use among beneficiaries with disabilities. from JAMA Internal Medicine Online First https://ift.tt/wJpknXl

Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Type 2 Diabetes

This comparative effectiveness research study examines the outcomes of treatment with sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, or dipeptidyl peptidase-4 inhibitors for patients with type 2 diabetes and chronic obstructive pulmonary disease. from JAMA Internal Medicine Online First https://ift.tt/rnaqZSH

Errors in Figure

Health Policy from JAMA Health Forum New Online https://ift.tt/ikMtyzq

Changes in US Primary Care Access and Capabilities During the COVID-19 Pandemic

This cohort study describes US primary care practices’ accessibility and capabilities and examines recent changes. from JAMA Health Forum New Online https://ift.tt/0hknNa5

JAMA Health Forum

Health Policy from JAMA Health Forum New Online https://ift.tt/CGAamv4

New FDA Policies Could Limit the Full Value of AI in Medicine

This JAMA Forum discusses the ways in which recent changes to US Food and Drug Administration (FDA) policies related to the regulation of artificial intelligence (AI) have added new uncertainties for the use of AI tools in medicine. from JAMA Health Forum New Online https://ift.tt/fPzF4kY

Addressing the Health Impacts of Climate Change in Older Adults

This Viewpoint evaluates the health impacts of climate change among older adults and provides recommendations to safeguard their health and wellbeing. from JAMA Internal Medicine Online First https://ift.tt/xjnf2be